IL17A and cancer: The significant pathways in KEGG enrichment contain IL‐17, Tumour Necrosis Factor (TNF) signalling pathway, apoptosis, cancer, oxytocin signalling pathway, fluid shear stress and atherosclerosis (Figure 3C).